Topotecan + toripalimab for endometrial neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 12 Aug 2024: Trial registered, NCT06548763

The trials

NCT06548763: Oral Topotecan With Toripalimab for Patients With Endometrial Cancer

State
Not started
Phase
Phase 2
People
30 planned
Started
30 Nov 2024
Primary completion
30 Jun 2026
Arms
Topotecanwith Terriptylimab
Results
None posted
  1. 12 Aug 2024: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.